Neurodegenerative Disease Research Inc
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2020-03-02
- Employees
- -
- Market Cap
- -
- Website
- https://www.ndrinc.org/
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Neurodegenerative Disease Research Inc
- Target Recruit Count
- 24
- Registration Number
- NCT05978908
- Locations
- 🇺🇸
Hassman Research Inc, Berlin, New Jersey, United States
News
No news found